Latest news
Alnylam Pharmaceuticals (ALNY) On Lowered TTR Guidance And What It Means For Valuation - simplywall.stsimplywall.st · Thu, 06 Aug 2026 14:12:21 GMTALNY Investors Have Opportunity to Join Alnylam Pharmaceuticals, Inc. Fraud Investigation with SBS Law - FinancialContentFinancialContent · Mon, 03 Aug 2026 22:20:00 GMTAlnylam: AMVUTTRA Revenue Tops $1 Billion, But Pent-Up Demand Normalization Triggers Guidance Cut - Pulse 2.0Pulse 2.0 · Sun, 02 Aug 2026 21:33:44 GMTAlnylam price target lowered to $420 from $468 at Raymond James - TipRanksTipRanks · Fri, 31 Jul 2026 14:49:36 GMTAlnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress - AlnylamAlnylam · Thu, 30 Jul 2026 07:00:00 GMT